Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 25

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

489	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	02/21/2014 4:07:13 PM
488	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	02/21/2014 2:51:38 PM
487	$NVLX Nuvilex Ahead of the Curve on	stocklegend	02/21/2014 2:18:17 PM
486	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	02/21/2014 12:26:07 PM
485	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	02/21/2014 11:21:27 AM
484	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	02/21/2014 10:33:37 AM
483	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	02/21/2014 9:42:13 AM
482	$NVLX Nuvilex Begins Making Moves at its	stocklegend	02/21/2014 9:18:15 AM
481	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	02/21/2014 8:57:05 AM
480	$NVLX Nuvilex Listed in Forbes Article on	stocklegend	02/20/2014 3:40:15 PM
479	$NVLX - Nuvilex COO Talks Medical Marijuana in NY	stocklegend	02/20/2014 2:26:41 PM
478	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	02/20/2014 1:35:08 PM
477	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	02/20/2014 12:39:09 PM
476	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	02/20/2014 11:30:17 AM
475	$NVLX - Nuvilex Restructures to Focus on	stocklegend	02/20/2014 10:48:33 AM
474	$NVLX - Nuvilex Restructures to Focus on	stocklegend	02/20/2014 10:08:03 AM
473	NVLX news:	stocklegend	02/20/2014 9:09:47 AM
472	$NVLX - Nuvilex Contracts with Inno Biologics to	stocklegend	02/20/2014 9:07:31 AM
471	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	02/20/2014 8:44:03 AM
470	Did everyone see the NVLX news yesterday? Nuvilex	Tandrel	02/20/2014 8:39:35 AM
469	$NVLX Nuvilex Completes Acquisition of	stocklegend	02/19/2014 3:55:33 PM
468	$NVLX Nuvilex Accelerates Development of	stocklegend	02/19/2014 3:55:19 PM
467	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	02/19/2014 1:59:33 PM
466	$NVLX Nuvilex Ahead of the Curve on	stocklegend	02/19/2014 1:28:09 PM
465	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	02/19/2014 12:06:10 PM
464	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	02/19/2014 11:41:44 AM
463	NVLX news"	stocklegend	02/19/2014 11:20:52 AM
462	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	02/19/2014 11:20:32 AM
461	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	02/19/2014 8:57:18 AM
460	Nuvilex is a biotechnology company with the	Tandrel	02/19/2014 8:44:50 AM
459	$NVLX Nuvilex Completes Acquisition of	stocklegend	02/18/2014 3:32:41 PM
458	$NVLX Nuvilex Accelerates Development of	stocklegend	02/18/2014 2:59:30 PM
457	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	02/18/2014 2:24:18 PM
456	$NVLX Nuvilex Ahead of the Curve on	stocklegend	02/18/2014 1:32:50 PM
455	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	02/18/2014 12:37:45 PM
454	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	02/18/2014 12:00:50 PM
453	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	02/18/2014 9:57:19 AM
452	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	02/18/2014 9:27:33 AM
451	$NVLX Nuvilex Begins Making Moves at its	stocklegend	02/18/2014 9:08:29 AM
450	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	02/18/2014 8:49:57 AM
449	$NVLX Nuvilex Completes Acquisition of	stocklegend	02/14/2014 2:11:37 PM
448	$NVLX Nuvilex Accelerates Development of	stocklegend	02/14/2014 1:58:16 PM
447	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	02/14/2014 1:14:33 PM
446	$NVLX Nuvilex Ahead of the Curve on	stocklegend	02/14/2014 12:07:50 PM
445	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	02/14/2014 11:52:37 AM
444	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	02/14/2014 11:35:15 AM
443	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	02/14/2014 10:23:48 AM
442	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	02/14/2014 10:03:31 AM
441	Nuvilex has received plenty of hype over their	Tandrel	02/14/2014 9:22:14 AM
440	$NVLX Nuvilex Begins Making Moves at its	stocklegend	02/14/2014 9:19:43 AM

Newer

Older

Recent Articles

• COP29 Climate Negotiations Yield Uncertain Business Prospects
• Gold Prices Dip as Tensions Ease Between Conflict Factions
• Dogecoin Eyes $1 as Bitcoin Struggles with Key Resistance
• Marc Benioff Envisions the Future of AI Beyond Chatbots
• Adani Group Share Recovery Amid Recent Legal Challenges
• Asian Market Rally: Cyclical Stocks Lead Gains Amid Optimism
• Australia's New Social Media Rules for Under-16s Explained
• Apple CEO's Beijing Visit Boosts Supplier Stocks Significantly
• Examining the Overvaluation of MicroStrategy Stock Today
• Light & Wonder, Inc.: Legal Scrutiny and Stockholder Insights
• Australia's Bold Move to Safeguard Children's Privacy Online
• Pathway to Growth: Palantir's Ambitious AI Future and Price Target
• Challenges Faced by Chinese Startups Amidst Investment Landscape
• Explore the Growth of Bluesky Amid Social Media Changes
• Elon Musk Amused by Bitcoin's Dip After Analyst's Praise
• Mynaric AG Faces Class Action Lawsuit: What Investors Should Know
• Iris Energy Investors Urged to Join Class Action Lawsuit
• Terran Orbital Faces Class Action Lawsuit: What Investors Should Know
• Franklin Resources Faces Investigation: What Investors Should Know
• Class Action Lawsuit Filed Against Xiao-I Corporation: Key Insights
• Quanterix Under Investigation for Financial Mismanagement Concerns
• Evolv Technologies Faces Class Action Lawsuit Amid Financial Concerns
• Marqeta Faces Legal Scrutiny Amid Revenue Forecast Cuts
• Investigation into The Estée Lauder Companies, Inc. Begins
• Class Action Lawsuit Impacting iLearningEngines Investors
• Flux Power's Legal Challenges: What Investors Should Know
• Class Action Lawsuit Filed Against Acadia Healthcare: Key Insights
• Explore Apple’s Exciting Black Friday Gift Card Promotions
• ONEOK Expands Reach with $4.3 Billion EnLink Acquisition
• Investors on Alert: Class Action Lawsuit Filed Against WM Technology
• Adani Group Faces Bond Market Turmoil Amid Fraud Claims
• Impact of New Tax Policies on British Business Investment Trends
• Strong Demand for Electric Vehicles Anticipated Until 2024
• Bitcoin's Resilience Amid Market Fluctuations This Thanksgiving
• SG Fleet Group Surges Amid $785 Million Buyout Talks
• Intel Adjusts to Reduced CHIPS Act Funding Amid Challenges
• U.S. Government Adjusts Intel's Chips Grant to Below $8 Billion
• Oil Prices Stabilize: Middle East Tensions and Ceasefire Talks
• Geopolitical Tensions Propel Oil Prices: A Two-Week Overview
• Cassava Sciences Announces Important Corporate Conference Call
• Confidence Boost in BioPharma: Impact of Makary's Nomination
• Air New Zealand Anticipates Lower Earnings Amid Engine Woes
• Wedbush Boosts Ratings for Snowflake and Elastic Amid AI Surge
• Market Reaction to Scott Bessent's U.S. Treasury Role
• Investors Encouraged to Act on Humacyte Class Action Lawsuit
• Australian Regulator Keeps Home Loan Rules Amid Job Market Concerns
• Dollar's Shift: Analyzing Market Reactions After Bessent's Pick
• U.S. Stock Futures Surge with Trump’s Treasury Nominee Scott Bessent
• Class Action Lawsuit Announced Against Acadia Healthcare Company
• McDonald's Invests $100 Million to Restore Customer Trust